{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:51:26Z","timestamp":1793508686241,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T00:00:00Z","timestamp":1731196800000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U54DK083909"],"award-info":[{"award-number":["U54DK083909"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1K23AR079586-01"],"award-info":[{"award-number":["1K23AR079586-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016650","name":"Rare Diseases Clinical Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jaad.2022.08.036","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T11:05:00Z","timestamp":1661598300000},"page":"1227-1237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria"],"prefix":"10.1016","volume":"89","author":[{"given":"Amy K.","family":"Dickey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetanshi","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siob\u00e1n B.","family":"Keel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon W.","family":"Beaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina B.","family":"Elmariah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika L.","family":"Erwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Goddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karli","family":"Hedstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Leaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Kazamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Mazepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Liang","family":"Philpotts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya","family":"Raef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Rudnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnam","family":"Saberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Thapar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Ungar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Balwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jaad.2022.08.036_bib1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2017.1557","article-title":"Clinical, biochemical, and genetic characterization of North American patients with erythropoietic protoporphyria and X-linked protoporphyria","volume":"153","author":"Balwani","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2119\/molmed.2012.00340","volume":"19","author":"Balwani","year":"2013","journal-title":"Mol Med"},{"issue":"4","key":"10.1016\/j.jaad.2022.08.036_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/1011-1344(91)80015-A","article-title":"Mechanisms of photosensitivity in porphyric patients with special emphasis on erythropoietic protoporphyria","volume":"10","author":"Brun","year":"1991","journal-title":"J Photochem Photobiol B"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib4","first-page":"9","article-title":"Evaluating quality of life tools in North American patients with erythropoietic protoporphyria and X-linked protoporphyria","volume":"50","author":"Naik","year":"2019","journal-title":"JIMD Rep"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.036_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2133.2006.07472.x","article-title":"Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life","volume":"155","author":"Holme","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2022.08.036_bib6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpeds.2018.06.001","article-title":"Diagnostic delay in erythropoietic protoporphyria","volume":"202","author":"Lala","year":"2018","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.036_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2796.2010.02283.x","article-title":"Delayed diagnosis and diminished quality of life in erythropoietic protoporphyria: results of a cross-sectional study in Sweden","volume":"269","author":"Frank","year":"2011","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41436-020-00951-8","article-title":"Evidence in the UK Biobank for the underdiagnosis of erythropoietic protoporphyria","volume":"23","author":"Dickey","year":"2021","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.jaad.2022.08.036_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","article-title":"The incidence of inherited porphyrias in Europe","volume":"36","author":"Elder","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jaad.2022.08.036_bib10","author":"Higgins"},{"issue":"7716","key":"10.1016\/j.jaad.2022.08.036_bib11","first-page":"332","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10826079608006285","article-title":"Determination of erythrocyte porphyrins by epi-illumination fluorescence microscope with capillary electrophoresis","volume":"19","author":"Yao","year":"1996","journal-title":"J Liq Chromatogr Relat Technol"},{"issue":"7","key":"10.1016\/j.jaad.2022.08.036_bib16","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/jbio.201200228","article-title":"Dual-wavelength excitation for fluorescence-based quantification of zinc protoporphyrin IX and protoporphyrin IX in whole blood","volume":"7","author":"Hennig","year":"2014","journal-title":"J Biophotonics"},{"issue":"12","key":"10.1016\/j.jaad.2022.08.036_bib17","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1373\/clinchem.2015.245456","article-title":"Pitfalls in erythrocyte protoporphyrin measurement for diagnosis and monitoring of protoporphyrias","volume":"61","author":"Gou","year":"2015","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.jaad.2022.08.036_bib19","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/clinchem\/45.7.1070","article-title":"Plasma porphyrins in the porphyrias","volume":"45","author":"Hindmarsh","year":"1999","journal-title":"Clin Chem"},{"issue":"7386","key":"10.1016\/j.jaad.2022.08.036_bib20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0140-6736(65)91714-9","article-title":"Biochemical and fluorescence-microscopy screening-tests for erythropoietic protoporphyria","volume":"1","author":"Rimington","year":"1965","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jaad.2022.08.036_bib21","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0009-9120(99)00067-3","article-title":"Biochemical differentiation of the porphyrias","volume":"32","author":"Hindmarsh","year":"1999","journal-title":"Clin Biochem"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.036_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1067\/mjd.2000.107498","article-title":"Vascular changes in erythropoietic protoporphyria: histopathologic and immunohistochemical study","volume":"43","author":"Timonen","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/498620","article-title":"Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria","volume":"78","author":"Gouya","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.036_bib24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2008.08.003","article-title":"C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload","volume":"83","author":"Whatley","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib25","first-page":"84","article-title":"A systematic review of treatment options for dermal photosensitivity in erythropoietic protoporphyria","volume":"55","author":"Minder","year":"2009","journal-title":"Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMoa1411481","article-title":"Afamelanotide for erythropoietic protoporphyria","volume":"373","author":"Langendonk","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/17512433.2014.956089","article-title":"Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria","volume":"8","author":"Minder","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.036_bib28","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/bjd.13598","article-title":"Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria","volume":"172","author":"Biolcati","year":"2015","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.08.036_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13023-020-01505-6","article-title":"Increased phototoxic burn tolerance time and quality of life in patients with erythropoietic protoporphyria treated with afamelanotide-a three years observational study","volume":"15","author":"Barman-Aks\u00f6zen","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"10.1016\/j.jaad.2022.08.036_bib30","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/molecules25071537","article-title":"Photoprotection and skin pigmentation: melanin-related molecules and some other new agents obtained from natural sources","volume":"25","author":"Solano","year":"2020","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.jaad.2022.08.036_bib31","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archderm.1979.04010120001002","article-title":"Phototesting as an objective measure of improvement in erythropoietic protoporphyria","volume":"115","author":"Mathews-Roth","year":"1979","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000250566","article-title":"Beta-carotene in erythropoietic protoporphyria: 5 years' experience","volume":"159","author":"Thomsen","year":"1979","journal-title":"Dermatologica"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.036_bib33","first-page":"244","article-title":"A double-blind study of cysteine photoprotection in erythropoietic protoporphyria","volume":"10","author":"Mathews-Roth","year":"1994","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.036_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1034\/j.1600-0781.2002.02790.x","article-title":"Long-term treatment of erythropoietic protoporphyria with cysteine","volume":"18","author":"Mathews-Roth","year":"2002","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"5","key":"10.1016\/j.jaad.2022.08.036_bib35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12328-017-0760-1","article-title":"Cimetidine\/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury","volume":"10","author":"Fujimori","year":"2017","journal-title":"Clin J Gastroenterol"},{"issue":"11","key":"10.1016\/j.jaad.2022.08.036_bib36","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/jamadermatol.2016.2303","article-title":"Novel treatment using cimetidine for erythropoietic protoporphyria in children","volume":"152","author":"Tu","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.036_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2019.07.017","article-title":"Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria","volume":"128","author":"Parker","year":"2019","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.jaad.2022.08.036_bib38","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1111\/ajd.13033","article-title":"Warfarin ineffective as symptomatic therapy for erythropoietic protoporphyria","volume":"60","author":"Doolan","year":"2019","journal-title":"Australas J Dermatol"},{"issue":"445 S","key":"10.1016\/j.jaad.2022.08.036_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.0954-6820.1966.tb02338.x","article-title":"Erythropoietic Protoporphyria: a study of known cases in Sweden","volume":"179","author":"Haeger-Aronsen","year":"1966","journal-title":"Acta Med Scand"},{"issue":"5","key":"10.1016\/j.jaad.2022.08.036_bib40","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1365-2133.2011.10715.x","article-title":"Zinc sulphate: a new concept of treatment of erythropoietic protoporphyria","volume":"166","author":"Petersen","year":"2012","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.036_bib41","first-page":"245","article-title":"Protoporphyrin photosensitivity cannot be attenuated by oral N-acetylcysteine","volume":"9","author":"Bijlmer-Iest","year":"1992","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0781.1996.tb00240.x","article-title":"A double-blind, placebo-controlled, crossover trial of oral vitamin C in erythropoietic protoporphyria","volume":"12","author":"Boffa","year":"1996","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"4","key":"10.1016\/j.jaad.2022.08.036_bib43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2230.2002.10321.x","article-title":"Dietary fish oils as a therapeutic option in erythropoietic protoporphyria","volume":"27","author":"Chakrabarti","year":"2002","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.036_bib44","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archderm.1966.01600300006002","article-title":"Erythropoietic protoporphyria (antea lipoid proteinosis) in sisters. A therapeutic trial with adenosine monophosphate","volume":"94","author":"Cripps","year":"1966","journal-title":"Arch Dermatol"},{"issue":"25","key":"10.1016\/j.jaad.2022.08.036_bib45","first-page":"1050","article-title":"The effects of canthaxanthin on the photocutaneous manifestations of porphyria","volume":"54","author":"Eales","year":"1978","journal-title":"South Afr Med J"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.036_bib46","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1365-2133.1990.tb06270.x","article-title":"Inhibition of photosensitivity in erythropoietic protoporphyria with terfenadine","volume":"122","author":"Farr","year":"1990","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2022.08.036_bib47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000253997","article-title":"Some aspects of erythropoietic protoporphyria in The Netherlands","volume":"138","author":"Suurmond","year":"1969","journal-title":"Dermatologica"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.036_bib48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/1523-1747.ep12540600","article-title":"Studies of photoprotection against porphyrin photosensitization using dithiothreitol and glycerol","volume":"58","author":"Harber","year":"1972","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.08.036_bib49","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0190-9622(90)70043-H","article-title":"Relief of the photosensitivity of erythropoietic protoporphyria by pyridoxine","volume":"22","author":"Ross","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000246484","article-title":"Treatment of erythropoietic protoporphyria with hydroxyethylrutosides","volume":"191","author":"Schoemaker","year":"1995","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.036_bib51","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2133.1977.tb14273.x","article-title":"The long term treatment with B-carotene in erythropoietic protoporphyria: a controlled trial","volume":"97","author":"Corbett","year":"1977","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2022.08.036_bib52","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archderm.1977.01640090077011","article-title":"Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases","volume":"113","author":"Mathews-Roth","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2022.08.036_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood-2020-142467","article-title":"Erythropoietic protoporphyria: phase 2 clinical trial results evaluating the safety and effectiveness of Dersimelagon (MT-7117), an oral MC1R agonist","volume":"136","author":"Balwani","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.036_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2133.1991.tb00570.x","article-title":"Sunscreen protection against UVB, UVA and blue light: an in\u00a0vivo and in\u00a0vitro comparison","volume":"124","author":"Diffey","year":"1991","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.036_bib55","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000251455","article-title":"Protection against long ultraviolet and\/or visible light with topical dihydroxyacetone: implications for the mechanism of action of the sunscreen combination, dihydroxyacetone\/naphthoquinone","volume":"150","author":"Fusaro","year":"1975","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.036_bib56","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1365-2133.1995.tb16955.x","article-title":"Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses","volume":"132","author":"Collins","year":"1995","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2022.08.036_bib57","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bjd.12714","article-title":"Narrowband ultraviolet B phototherapy in erythropoietic protoporphyria: case series","volume":"170","author":"Sivaramakrishnan","year":"2014","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2022.08.036_bib58","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jaad.2019.04.010","article-title":"Pitfalls and proposed solutions for patient communication about erythropoietic protoporphyria: a survey of parents and adult patients","volume":"81","author":"Dickey","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.036_bib59","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ymgme.2019.01.023","article-title":"Psychosocial issues in erythropoietic protoporphyria - the perspective of parents, children, and young adults: a qualitative study","volume":"128","author":"Naik","year":"2019","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.jaad.2022.08.036_bib60","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1365-2133.1987.tb05904.x","article-title":"Erythropoietic protoporphyria: a study of its psychosocial aspects","volume":"116","author":"Rufener","year":"1987","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib61","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archderm.1974.01630070026004","article-title":"Erythropoietic protoporphyria. A clinical study based on 29 cases in 14 families","volume":"110","author":"Schmidt","year":"1974","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2022.08.036_bib62","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1182\/blood-2007-04-088120","article-title":"Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria","volume":"110","author":"Holme","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib63","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcmd.2014.07.017","article-title":"In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability","volume":"54","author":"Barman-Aks\u00f6zen","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib64","first-page":"45","article-title":"Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria","volume":"55","author":"Delaby","year":"2009","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"2","key":"10.1016\/j.jaad.2022.08.036_bib65","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood-2006-04-014142","article-title":"Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice","volume":"109","author":"Lyoumi","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.036_bib66","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10545-017-0017-7","article-title":"Disturbed iron\u00a0metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity","volume":"40","author":"Barman-Aksoezen","year":"2017","journal-title":"J Inherit Metab Dis"},{"issue":"10","key":"10.1016\/j.jaad.2022.08.036_bib67","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/eci.12503","article-title":"Homeostasis of iron and hepcidin in erythropoietic protoporphyria","volume":"45","author":"Bossi","year":"2015","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.jaad.2022.08.036_bib68","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/bjh.12485","article-title":"Clinical and biochemical improvement following low-dose intravenous iron therapy in a patient with erythropoietic protoporphyria","volume":"163","author":"Bentley","year":"2013","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.036_bib69","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bjh.13612","article-title":"X-linked protoporphyria: iron supplementation improves protoporphyrin overload, liver damage and anaemia","volume":"173","author":"Landefeld","year":"2016","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.jaad.2022.08.036_bib70","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/j.1460-2075.1991.tb07716.x","article-title":"Identification of a novel iron-responsive element in murine and human erythroid delta-aminolevulinic acid synthase mRNA","volume":"10","author":"Dandekar","year":"1991","journal-title":"EMBO J"},{"issue":"7","key":"10.1016\/j.jaad.2022.08.036_bib71","first-page":"1009","article-title":"Liver disease in erythropoietic protoporphyria: insights and implications for management","volume":"56","author":"Anstey","year":"2007","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.jaad.2022.08.036_bib72","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1136\/jmg.2003.016121","article-title":"Autosomal recessive\u00a0erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease","volume":"41","author":"Whatley","year":"2004","journal-title":"J Med Genet"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.036_bib73","first-page":"645","article-title":"Erythropoietic protoporphyria and early onset of cholestasis","volume":"54","author":"Khalili","year":"2012","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.jaad.2022.08.036_bib74","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1542\/peds.2016-1625","article-title":"Erythropoietic protoporphyria: initial diagnosis with cholestatic liver disease","volume":"141","author":"Coffey","year":"2018","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.036_bib75","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2133.1978.tb06163.x","article-title":"Erythropoietic protoporphyria: hepatic cirrhosis","volume":"98","author":"Cripps","year":"1978","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib76","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2133.2008.08616.x","article-title":"Serum 25-hydroxyvitamin D in erythropoietic protoporphyria","volume":"159","author":"Holme","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2022.08.036_bib77","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10545-008-1037-0","article-title":"Vitamin D deficiency in patients with erythropoietic protoporphyria","volume":"33","author":"Spelt","year":"2010","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib78","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2133.2008.08581.x","article-title":"The quality of life of 790 patients with photodermatoses","volume":"159","author":"Jong","year":"2008","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.08.036_bib79","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/0144361031000074817","article-title":"Erythropoietic protoporphyria in pregnancy","volume":"23","author":"Jacquemyn","year":"2003","journal-title":"J Obstet Gynaecol"},{"issue":"7","key":"10.1016\/j.jaad.2022.08.036_bib80","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/01443610600930670","article-title":"Erythropoietic protoporphyria in pregnancy","volume":"26","author":"Madu","year":"2006","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.jaad.2022.08.036_bib81","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/01443615.2020.1777954","article-title":"Erythropoietic protoporphyria in pregnancy","volume":"41","author":"Nevins","year":"2021","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib82","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2133.1998.02333.x","article-title":"Erythropoietic protoporphyria improving during pregnancy","volume":"139","author":"Bewley","year":"1998","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib83","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0190-9622(97)70323-2","article-title":"Human protoporphyria: reduced cutaneous photosensitivity and lower erythrocyte porphyrin levels during pregnancy","volume":"36","author":"Poh-Fitzpatrick","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.036_bib84","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1111\/bjd.15228","article-title":"Patients with erythropoietic protoporphyria have reduced erythrocyte protoporphyrin IX from early in pregnancy","volume":"177","author":"Heerfordt","year":"2017","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.036_bib85","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10545-010-9231-2","article-title":"Excess risk of adverse\u00a0pregnancy outcomes in women with porphyria: a population-based cohort study","volume":"34","author":"Toll\u00e5nes","year":"2011","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.036_bib86","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/bjd.12242","article-title":"Maternal and fetal outcome in Swedish women with erythropoietic protoporphyria","volume":"168","author":"Wahlin","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.08.036_bib87","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1469-1809.1984.tb01006.x","article-title":"Genetic aspects of erythropoietic protoporphyria","volume":"48","author":"Went","year":"1984","journal-title":"Ann Hum Genet"},{"issue":"9","key":"10.1016\/j.jaad.2022.08.036_bib88","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/lt.21527","article-title":"Protection from phototoxic injury during surgery and endoscopy in erythropoietic protoporphyria","volume":"14","author":"Wahlin","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jaad.2022.08.036_bib89","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/j.jaad.2020.02.024","article-title":"A multi-disciplinary approach utilizing filters for surgical procedures in erythropoietic protoporphyria","volume":"83","author":"Levoska","year":"2020","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222026111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222026111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:36:42Z","timestamp":1777523802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222026111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0190962222026111"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.08.036","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}